Regulatory Capital Treatment of Settled to Market Cleared OTC Derivative Contracts

Published on:
December 18, 2015

SIFMA provided comments to multiple agencies to inform them of a forthcoming change in market practice for cleared derivatives. Specifically, central clearing counterparties (CCPs) have been working with other market participants (including U.S. and European clearing member firms, law firms and accounting firms) to amend or clarify their terms, rules, and procedures to determine circumstances under which the payment of variation margin (VM) for over-the-counter (OTC) derivatives that are cleared through CCPs constitutes settlement of the exposure, as opposed to collateralization. While the status of implementation of these changes varies across CCPs and clearing member firms, SIFMA wanted to make you these agencies aware of the regulatory capital consequences – resulting from the regulatory capital framework’s recognition of settlement as exposure-reducing – about which clearing member firms may notify their supervisors in coming months.

Details

Download

More Content

  • Letters
    Nov 09, 2026

    Political Contributions by Certain Investment Advisers (SIFMA AMG)

    SIFMA AMG supports the SEC’s proposal to rescind the investment adviser pay-to-play rule, citing compliance burdens, costs and restrictions on political speech.
  • Letters
    Nov 09, 2026

    Political Contributions by Certain Investment Advisers

    SIFMA comments on the SEC’s proposal to rescind the political contributions rule for investment advisers, citing compliance burdens and existing safeguards.
  • Amicus Briefs
    Nov 06, 2026

    Blockchain Assoc. and Crypto Council for Innovation v. IL

Get the latest trends, stats, and research on financial markets and securities.